Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AGNPF
Recent news which mentions AGNPF
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Tickers
AGNPF
ATAI
CMND
CMPS
Tags
PSIL
ENVB
CMND
From
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Tickers
AGNPF
Tags
Psychedelics
Benzinga
Biotech
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
AGNPF
Global
Amanda Feilding
From
Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
August 08, 2023
Tickers
AGNPF
Tags
Psychedelics
Penny Stocks
Benzinga
From
Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
June 05, 2023
Tickers
AGNPF
Tags
DMT Clinical Trial
AGN Neuro
Psychedelics
From
Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
April 04, 2023
Tickers
AGNPF
CMND
PSYGF
Tags
Psychedelics Financing
Diamond Therapeutics Inc/
Psychedelics
From
Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
April 04, 2023
Tickers
AGNPF
Tags
News
Penny Stocks
Market News
From
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
Tickers
AGNPF
AWKNF
BRAXF
CMPS
Tags
BRAXF
PSIL
Market News
From
Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
March 03, 2023
Tickers
AGNPF
Tags
AGNPF
Benzinga
Penny Stocks
From
Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
March 01, 2023
Tickers
AGNPF
IPOS
Tags
Psychedelics
Benzinga
IPOs
From
Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
Tickers
AGNPF
AWKNF
CMND
CYBN
Tags
Psychedelics
SPRC
CYBN
From
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Tickers
AGNPF
AWKNF
CYBN
DMTTF
Tags
KONEF
Benzinga
AWKNF
From
Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
February 21, 2023
Tickers
AGNPF
TBI
Tags
General
Legal
Management
From
Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
February 16, 2023
Tickers
AGNPF
Tags
AGNPF
Markets
Cannabis
From
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
January 18, 2023
Tickers
AGNPF
DMT
Tags
Psychedelic/Assisted Therapies
Human Stroke
Benzinga
From
Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
January 03, 2023
Tickers
AGNPF
Tags
Financing
Blackhawk growth corp
AGN Neuro
From
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
December 15, 2022
Tickers
AGNPF
ATAI
FLHLF
Tags
Management
Benjamin Lightburn
General
From
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Tickers
AGNPF
BMNDF
CMND
CMPS
Tags
RVLWF
Elon Musk
Congressional Psychedelics Caucus
From
Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
November 16, 2022
Tickers
AGNPF
Tags
Psychedelics
Benzinga
DMT Clinical Trial
From
Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
October 24, 2022
Tickers
AGNPF
Tags
Yale University
DMT Clinical Trial
Psychedelics
From
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
Tickers
AGNPF
DMT
Tags
Benzinga
Psychedelics
Management
From
Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
September 08, 2022
Tickers
AGNPF
Tags
Market News
Cannabis
Markets
From
Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
August 23, 2022
Tickers
AGNPF
Tags
Penny Stocks
News
Christopher J/ Moreau
From
Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
July 18, 2022
Tickers
AGNPF
Tags
News
Briefs
Biotech
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
BETRF
Fabio Chianelli
Cannabis
From
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
HAVLF
EHVVF
TRIP
From
Benzinga
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
September 13, 2021
Tickers
AGNPF
ALID
ATAI
FTRP
Tags
Clerkenwell Health
ALID
HAVLF
From
Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
August 02, 2021
Tickers
AGNPF
ATOS
GILD
LLY
Tags
LLY
SRNE
Stocks to Sell
From
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.